TUESDAY, JUNE 9

12:00 - 2:00 pm Registration for RNAi for Therapeutic Indications and RNAi for Target Identification and Validation Conferences

EXECUTIVE FORUM 
[Shared Session]

Moderator: Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals Corp.

I. Surveying RNAi Opportunities: From Tools to Therapies

Participants:

Arthur M. Krieg, M.D., Chief Scientific Officer, Research Technology Center, Pfizer Inc.

Elena Feinstein, M.D., Chief Scientific Officer, Quark Pharmaceuticals Inc.

Klaus Giese, Ph.D., Chief Scientific Officer, Silence Therapeutics PLC

Thomas Singer D.A.B.T. Global Head of Non-Clinical Safety, F. Hoffmann-La Roche AG

3:35 Sponsored Presentation (Opportunity Available)

3:50 Networking Refreshment Break Poster and Exhibit Viewing

II. Navigating the Intellectual Property Landscape

Participants:

Kathleen M. Williams, Ph.D, J.D., Intellectual Property Attorney, Partner, Edwards Angell Palmer & Dodge LLP

Rochelle K. Seide, Ph.D., Senior Counsel, Schwegman, Lundberg & Woessner, P.A.

Steven L. Highlander, Ph.D., Partner, Intellectual Property, Fulbright & Jaworski LLP

5:45 End of Day

For partnering and sponsorship information, please contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5483
Email: jstroup@healthtech.com